Janet Lynch Lambert, CEO of the Alliance for Regenerative Medicine (ARM), discusses the association’s aims and membership, the importance of creating a supportive reimbursement environment for regenerative medicine, and the huge and expanding need for education in this critical area.
What was the initial inspiration behind setting up the Alliance for Regenerative Medicine (ARM)?
"Having enjoyed a highly positive start-up phase, we now need to put the right elements in place to ensure a successful phase two and continue delivering value for our members, the sector and the patients who rely on the successful commercialization of these therapies."
